Cervical Cancer Diagnostic Tests Market is Expected to Grow at a CAGR of 6.1% from 2014 to 2020

1
Based on the test types - (Pap Smear tests,
Colposcopy, HPV Testing, Endocervical Curettage
(ECC) and Others (Cone Biopsy and Loop
Electrosurgical Excision Procedure
(LEEPForecast From 2014 - 2020
Cervical Cancer Diagnostic Tests Market
2
Table of Content
Sr. No. Content
Chapter1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Global Cervical Cancer Diagnostic Tests Market, by Type of Test
Chapter 5 Global Cervical Cancer Diagnostics Tests Market, by Geography
Chapter 6 Recommendations
Chapter 7 Company Profiles
3
Cervical Cancer Diagnostic Tests Market Snapshot

• According to the World Health Organization (WHO),
  cervical cancer is the second most commonly
  prevalent cancer and the third greatest cause of
  death in women, with 530,000 new cases discovered
  each year.
• Increasing number of HIV-infected individuals and
  suppressed immune system are the primary factors
  contributing to the growth of the global cervical
  cancer diagnostic tests market.
• Global cervical cancer diagnostic tests market is
  segmented based on types of tests performed for
  the diagnosis of cancer patients.

4
Reports Highlights

• Global cervical cancer diagnostic tests market
  was valued at USD 5.9 billion in 2013 and is
  expected to grow at a CAGR of 6.1 from 2014 to
  2020, to reach an estimated value of USD 8.9
  billion in 2020
• Rising Incidence of Cervical Cancer Dialing
  Growth for Cervical Cancer Diagnostic Tests
  Market
• The growth of segment is mainly attributed to the
  rising awareness about cancer diagnosis and the
  high efficacy of the investigation at relatively
  low costs. HPV testing is expected to register a
  significant growth rate between 2014 and 2020,
• Key players - Abbott Laboratories, Becton,
  Dickinson and Company, and Hologic, Inc. Other
  companies include Guided Therapeutics, Femasys,
  Inc., OncoHealth Corp., Quest Diagnostics, Inc.,
  Roche Diagnostics, QIAGEN, and Zilico Ltd.

Request Sample
5
(No Transcript)